Income statement
USD
Annual
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 8M | 2K |
| Gross Profit | 0 | 0 | 0 | 3M | 475 |
| Operating Income | -7K | -2M | -129K | 2K | -1M |
| EBITDA | -22K | -2M | -69 | -2K | -1M |
| Net Income | -9K | -5M | -3M | -551K | -1M |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
-75.00%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 244 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Thunder Energies Corporation (TNRG) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 75.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +99.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +99.9%, free cash flow -30.8% with operating margin 0.0% and ROIC 0.1%. Stock Foundry combines TNRG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TNRG
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TNRG Max Drawdown
-99.67%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TNRG and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$2.2K
-100.0% YoY
FY Net Income
-$1.4M
-152.3% YoY
Free Cash Flow
-$170.5K
-1479.8% YoY
Revenue Growth
+0.0%
EPS Growth
+99.9%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 8M | 2K |
| Gross Profit | 0 | 0 | 0 | 3M | 475 |
| Operating Income | -7K | -2M | -129K | 2K | -1M |
| EBITDA | -22K | -2M | -69 | -2K | -1M |
| Net Income | -9K | -5M | -3M | -551K | -1M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 596 | 49K | 0 | 98K | 3K |
| Total Assets | 155K | 146K | 0 | 1M | 3K |
| Total Liabilities | 9M | 7M | 3M | 3M | 123K |
| Shareholder Equity | -9M | -7M | -3M | -1M | -120K |
| Total Debt | 751K | 2M | 509K | 237K | 57K |
| Net Debt | 750K | 2M | 509K | 878K | 54K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
155K
-167.5% YoY
Capital Expenditures
16K
+93.4% YoY
Free Cash Flow
171K
-1479.8% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
0.1%
Debt / Equity
-0.08x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.